Author:
Liang Cui,Ding Ming,Weng Xiang-qin,Sheng Yan,Wu Jing,Cai Xun
Funder
Natural Science Foundation of Shanghai
Subject
Toxicology,General Medicine,Food Science
Reference58 articles.
1. Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid , arsenic trioxide , and gemtuzumab;Abaza;Blood,2017
2. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models;Akinaga;Cancer Res.,1991
3. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia;Aribi;Cancer,2007
4. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins β and -δ in preadipocytes;Belmonte;Mol. Endocrinol.,2001
5. The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species;Cerioni;FEBS Lett.,2003